What is interventional treatment for liver cancer? Detailed introduction to common knowledge of interventional treatment for liver cancer

Interventional treatment of liver cancer is a minimally invasive treatment method that creates a tiny channel with a diameter of several millimeters in the blood vessels or skin, or through the body's original channels, and treats the lesion locally under the guidance of imaging equipment (angiography, fluoroscopy, CT, MR, B-ultrasound) without exposing the lesion through surgery.

In liver cancer, vascular interventional therapy is the most widely used in clinical practice. It mainly includes selective hepatic artery perfusion therapy, selective hepatic artery embolization, and selective hepatic artery chemoembolization. The specific technical methods of the three are the same, that is, a small incision of about 3-5 mm is punctured on the skin, a catheter is inserted from the artery to the liver cancer supply artery, and then the drug is administered through the catheter. The difference lies in the different drugs given.

Interventional therapy has been recognized as the first choice for treatment of advanced liver cancer. It uses local targeted drug perfusion, tumor vascular embolization, and argon-helium cryoablation to kill tumor cells in a concentrated manner, minimize tumor load (reduce the number and volume of malignant tumors), and combines CIK cell adoptive immunotherapy and anti-tumor angiogenesis drugs to achieve good clinical treatment results, effectively improve the quality of life of patients, and prolong survival time. It can also reverse the liver cancer stage of some patients, turning unresectable liver cancer cases into resectable liver cancer cases.